MOTS-C

Категорія:

Технічні характеристики:

Компанія: Synox Medicals
Active compound: MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-C)
Група: Metabolic Regulator
Підгрупа: Mitochondrial-Derived Peptide (MDP)
Дозування: 20 mg/pen
Application: As directed
Пакет продукту: Pre-filled injection pen
Вміст (активний): MOTS-C peptide
Утримує воду: Немає
ароматизація: Немає

Product Description

MOTS-C is a mitochondrial-derived peptide (MDP) involved in cellular metabolic regulation. It is encoded within mitochondrial DNA and has been studied for its role in energy homeostasis, insulin sensitivity, and metabolic adaptation. As a signaling peptide, MOTS-C influences pathways associated with glucose utilization and mitochondrial function. It is currently the subject of ongoing research in metabolic health and cellular performance.

Effects

MOTS-C has been studied for its potential role in enhancing metabolic flexibility, supporting glucose regulation, and improving cellular energy utilization. Research suggests it may influence AMPK-related pathways and mitochondrial activity. Observed outcomes in experimental settings include improved metabolic efficiency and support of energy balance mechanisms.

Side Effects

Reported side effects may include mild injection-site discomfort, temporary fatigue, headache, or transient flushing. Individual sensitivity may vary. As with other peptides, tolerability depends on preparation quality and administration conditions.

Stacking

MOTS-C is generally incorporated into metabolic-focused protocols and is often used as a standalone compound in research contexts. Combination with other metabolic peptides should be approached cautiously and evaluated for compatibility under professional supervision.